Normothermic perfusion of ischaemic porcine kidneys: An evaluation of ex vivo function and endothelin receptor antagonism

Journal of Nephrology

Volumn 22, Issue 1, 2009, Pages 144-151

  Mann, Christopher D ^a   Metcalfe, Matthew S ^a   Nicholson, Michael L ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

Endothelin antagonists; Normothermic perfusion; Renal transplantation

Indexed keywords

ENDOTHELIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CYCLO(TRP ASP PRO VAL LEU); CYCLO(TRP-ASP-PRO-VAL-LEU); CYCLOPEPTIDE; ENDOTHELIN RECEPTOR; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; OLIGOPEPTIDE; PIPERIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; GLUCOSURIA; HYPEROSMOLARITY; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY METABOLISM; KIDNEY PERFUSION; KIDNEY VASCULAR RESISTANCE; NONHUMAN; OXYGEN CONSUMPTION; SODIUM ABSORPTION; SWINE; TEMPERATURE DEPENDENCE; URINALYSIS; ANIMAL; BLOOD FLOW; DRUG ANTAGONISM; DRUG EFFECT; KIDNEY; PATHOPHYSIOLOGY; PHYSIOLOGY; REPERFUSION INJURY; TEMPERATURE; VASCULAR RESISTANCE; VASCULARIZATION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; KIDNEY; MODELS, ANIMAL; OLIGOPEPTIDES; OXYGEN CONSUMPTION; PEPTIDES, CYCLIC; PIPERIDINES; RECEPTORS, ENDOTHELIN; REGIONAL BLOOD FLOW; REPERFUSION INJURY; SWINE; TEMPERATURE; VASCULAR RESISTANCE;

EID: 66349104070     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Nicholson ML, Horsburgh T, Doughman TM, et al. Comparison of the results of renal transplants from conventional and non-heart-beating cadaveric donors. Transplant Proc. 1997;29:1386-1387.
2. Booster MH, Yin M, Stubenitsky BM, et al. Beneficial effect of machine perfusion on the preservation of renal microcirculatory integrity in ischaemically damaged kidneys. Transplant Proc. 1993;25:3012-3016.
3. Marshall V, Ross B, Smith M, Bartlett S, Freeman D. Organ and tissue preservation for transplantation: monitoring by 31P nuclear magnetic resonance. Transplant Proc. 1985;17:1693-1696.
4. Brasile L, Clarke J, Green E, Haisch C. The feasibility of organ preservation at warmer temperatures. Transplant Proc. 1996;28:349-351.
5. Stubenitsky BM, Booster MH, Brasile L, et al. Prospective evaluation of renal function. Transplant Proc. 2000;32:175-176.
6. Verhaar MC, Strachan FE, Newby DE, et al. Endothelin-A receptor antagonist-mediated vasodilation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade. Circulation. 1998;97:752-756.
7. Awane-Igata Y, Ikeda S, Watanabe T. Inhibitory effects of TAK-044 on endothelium induced vasoconstriction in various canine and porcine coronary arteries: a comparison with selective ETA and ETB receptor antagonists. Br J Pharmacol. 1997;120:516-522.
8. Strachan FE, Spratt JC, Wilkinson IB, Johnston NR, Gray GA, Webb DJ. Systemic blockade of the endothelin-B receptor increases peripheral vascular resistance in healthy men. Hypertension. 1999;33:581-585.
9. Montanari A, Biggi A, Carra N, et al. Endothelin-A blockade attenuates systemic and renal hemodynamic effects of LNAME in humans. Hypertension. 2000;35:518-523.
10. Ishikawa K, Ihara M, Noguchi K, et al. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci U S A. 1994;91:4892-4896.
11. A receptor subtype-specific antagonist in healthy subjects. Br J Pharmacol. 1998;124:930-934.
12. King AJ, Brenner BM, Anderson S. Endothelin: a potent renal and systemic vasoconstrictor peptide. Am J Physiol. 1989;256:F1051-F1058.
13. Gellai M, Jugus M, Fletcher T, DeWolf R, Nambi P. Reversal of postischemic acute renal failure with a selective endothelinA receptor antagonist in the rat. J Clin Invest. 1994;93:900-906.
14. Inman SR, Burns TE, Osgood RW, Plott WK, Lewis RM. Increased urinary excretion of endothelin during hypothermic perfusion preservation in kidneys subjected to preretrieval warm ischaemic injury. Transplantation. 2000;69:2187-2190.
15. Daemen JHC, Heineman E, Kootstra G. Viability assessment of non-heart-beating donor kidneys during machine preservation. Transplant Proc. 1995;27:2906-2907.
16. Tesi RJ, Elkhammas EA, Davies EA, Henry ML, Ferguson RM. Pulsatile kidney perfusion for evaluation of high-risk kidney donors safely expands the donor pool. Clin Transplant. 1994;8:134-138.
17. Matsuno N, Kozaki K, Degawa H, et al. Importance of machine perfusion flow in kidney preservation. Transplant Proc. 1999;31:2004-2005.
18. Brasile L, Green E, Haisch C. Ex vivo resuscitation of kidneys following postmortem warm ischaemia. Transplant Proc. 1997;29:3518-3519.
19. Stubenitsky BM, Booster MH, Brasile L, et al. Exsanguinous metabolic support perfusion: a new strategy to improve graft function after kidney transplantation. Transplantation. 2000;70:1254-1258.
20. Fuller BJ, Pegg DE, Walter CA, Green CJ. An isolated rabbit kidney preparation for use in organ preservation research. J Surg Res. 1977;22:128-142.
21. Pedersen EB, Thomsen IM, Fjordside LS. Effect of BQ-123, an endothelin antagonist, on renal hemodynamics, tubular function, vasoactive hormones, and blood pressure in healthy humans: a dose response study. Am J Hypertens. 2005;18:1578-1585.
22. Ohta K, Hirata Y, Shichuri M, et al. Urinary excretion of endothelin-1 in normal subjects and patients with renal disease. Kidney Int. 1991;39:307-311.
23. Kon V, Yoshioka T, Fogo A, Ichikawa I. Glomerular actions of endothelin in vivo. J Clin Invest. 1989;83:1762-1767.
24. Shibouta Y, Suzuki A, Shino H, et al. Pathophysiological role of endothelin in acute renal failure. Life Sci. 1990;46:1611-1618.
25. Erdogan H, Fadillioglu E, Emre MH. Protection from renal ischemia reperfusion injury by an endothelin-A receptor antagonist BQ-123 in relation to nitric oxide production. Toxicology. 2006;228:219-228.
26. Mino N, Kobayashi M, Nakajima A, et al. Protective effect of a selective endothelin receptor antagonist, BQ-123, in ischemic acute renal failure in rats. Eur J Pharmacol. 1992;221:77-83.
27. Chan L, Chittinandana A, Shapiro JI, Shanley PF, Schrier RW. Effect of an endothelin-receptor antagonist on ischemic acute renal failure. Am J Physiol. 1994;266:F135-F138.
28. Inman SR, Burns TE, Plott WK, Pomilee RA, Antonelli JA, Lewis RM. Endothelin receptor blockade during hypothermic perfusion preservation mitigates the adverse effect of preretrieval warm ischemic injury on posttransplant glomerular filtration rate. Transplantation. 2002;74:164-168.